Fidelity Investments’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $93M | Buy |
1,954,694
+737
| +0% | +$38.9K | ﹤0.01% | 1212 |
|
|
2025
Q4 | $102M | Buy |
1,953,957
+68,294
| +4% | +$4.09M | 0.01% | 1163 |
|
|
2025
Q3 | $122M | Sell |
1,885,663
-43,491
| -2% | -$2.5M | 0.01% | 1088 |
|
|
2025
Q2 | $93.8M | Sell |
1,929,154
-11,391
| -0.6% | -$441K | 0.01% | 1147 |
|
|
2025
Q1 | $66M | Sell |
1,940,545
-282,748
| -13% | -$12M | ﹤0.01% | 1262 |
|
|
2024
Q4 | $87.5M | Sell |
2,223,293
-152,873
| -6% | -$7.22M | 0.01% | 1176 |
|
|
2024
Q3 | $112M | Buy |
2,376,166
+23,075
| +1% | +$1.17M | 0.01% | 1058 |
|
|
2024
Q2 | $127M | Buy |
2,353,091
+113,408
| +5% | +$6.56M | 0.01% | 960 |
|
|
2024
Q1 | $153M | Buy |
2,239,683
+399,812
| +22% | +$28.6M | 0.01% | 896 |
|
|
2023
Q4 | $115M | Sell |
1,839,871
-217,543
| -11% | -$12M | 0.01% | 959 |
|
|
2023
Q3 | $93.4M | Sell |
2,057,414
-33,759
| -2% | -$1.74M | 0.01% | 1000 |
|
|
2023
Q2 | $117M | Sell |
2,091,173
-47,883
| -2% | -$2.72M | 0.01% | 920 |
|
|
2023
Q1 | $96.7M | Sell |
2,139,056
-45,328
| -2% | -$2.2M | 0.01% | 997 |
|
|
2022
Q4 | $88.8M | Buy |
2,184,384
+37,940
| +2% | +$2.01M | 0.01% | 1017 |
|
|
2022
Q3 | $140M | Buy |
2,146,444
+527,422
| +33% | +$38.2M | 0.01% | 820 |
|
|
2022
Q2 | $98.4M | Buy |
1,619,022
+357,400
| +28% | +$21M | 0.01% | 980 |
|
|
2022
Q1 | $79.2M | Buy |
1,261,622
+890,900
| +240% | +$55.9M | 0.01% | 1182 |
|
|
2021
Q4 | $28.1M | Sell |
370,722
-203,759
| -35% | -$17.8M | ﹤0.01% | 1662 |
|
|
2021
Q3 | $64.3M | Sell |
574,481
-2,246
| -0.4% | -$282K | 0.01% | 1310 |
|
|
2021
Q2 | $93.4M | Buy |
576,727
+8,805
| +2% | +$1.07M | 0.01% | 1148 |
|
|
2021
Q1 | $69.2M | Sell |
567,922
-339,867
| -37% | -$51.3M | 0.01% | 1238 |
|
|
2020
Q4 | $139M | Sell |
907,789
-40,664
| -4% | -$4.81M | 0.01% | 892 |
|
|
2020
Q3 | $79.3M | Sell |
948,453
-93,357
| -9% | -$8.28M | 0.01% | 1018 |
|
|
2020
Q2 | $76.6M | Buy |
1,041,810
+164,796
| +19% | +$9.64M | 0.01% | 988 |
|
|
2020
Q1 | $37.2M | Sell |
877,014
-75,355
| -8% | -$3.89M | 0.01% | 1142 |
|
|
2019
Q4 | $58M | Buy |
952,369
+398,012
| +72% | +$21.7M | 0.01% | 1144 |
|
|
2019
Q3 | $22.7M | Buy |
554,357
+256,088
| +86% | +$12.2M | ﹤0.01% | 1524 |
|
|
2019
Q2 | $14M | Buy |
298,269
+55,933
| +23% | +$2.24M | ﹤0.01% | 1763 |
|
|
2019
Q1 | $8.66M | Sell |
242,336
-73,500
| -23% | -$2.54M | ﹤0.01% | 1915 |
|
|
2018
Q4 | $9.02M | Buy |
315,836
+16,900
| +6% | +$588K | ﹤0.01% | 1837 |
|
|
2018
Q3 | $13.3M | Buy |
298,936
+101,028
| +51% | +$5.29M | ﹤0.01% | 1847 |
|
|
2018
Q2 | $11.6M | Buy |
+197,908
| New | +$11.3M | ﹤0.01% | 1904 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
NAMA